Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $681.94 billion, total revenue of $168.86 billion and a weighted average PE ratio of 38.97.
Market Cap
681.94B
Revenue
168.86B
Profits
17.5B
PE Ratio
38.97
Profit Margin
10.36%
Dividend Yield
0.24%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 176.04B | 0.93% | 1,102,101 | 45.20B |
| 2 | DHR | Danaher Corporation | 128.18B | 0.56% | 3,931,582 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.96B | 1.63% | 556,765 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 36.88B | 0.58% | 1,530,076 | 7.23B |
| 5 | WAT | Waters Corporation | 35.13B | 0.63% | 644,762 | 3.77B |
| 6 | NTRA | Natera, Inc. | 31.07B | 2.31% | 1,017,025 | 2.50B |
| 7 | IQV | IQVIA Holdings Inc. | 29.77B | -1.69% | 1,717,304 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 25.25B | 3.68% | 2,156,369 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 23.33B | 2.03% | 203,488 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.38B | -0.43% | 1,006,325 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 21.73B | -0.42% | 461,439 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 17.21B | -1.37% | 1,648,952 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.35B | 0.03% | 265,698 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 11.31B | 1.05% | 598,032 | 8.25B |
| 15 | RVTY | Revvity, Inc. | 11.22B | 0.89% | 933,964 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 9.08B | 0.51% | 421,266 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 7.65B | -0.13% | 2,450,874 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 5.03B | 6.07% | 2,642,095 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 4.78B | 2.80% | 751,949 | 354.54M |
| 20 | SHC | Sotera Health Company | 4.63B | 0.37% | 1,780,091 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.48B | 0.51% | 840,825 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 3.92B | 3.82% | 1,426,508 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | -0.80% | 2,835,905 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.57B | -0.07% | 398,339 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.82B | 2.34% | 979,717 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.44B | -0.54% | 816,925 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.24B | 4.83% | 728,046 | 412.82M |
| 28 | OPK | OPKO Health, Inc. | 1.06B | -1.41% | 2,596,362 | 581.12M |
| 29 | PSNL | Personalis, Inc. | 1.03B | 2.09% | 2,518,266 | 64.52M |
| 30 | CSTL | Castle Biosciences, Inc. | 625.56M | -0.36% | 219,920 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 520.87M | -1.82% | 159,249 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 408.02M | -0.23% | 1,128,269 | 829.00M |
| 33 | PRE | Prenetics Global Limited | 349.19M | -4.07% | 128,869 | 120.07M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 184.04M | 1.60% | 231,600 | 1.95M |
| 35 | BDSX | Biodesix, Inc. | 159.51M | 4.78% | 31,203 | 96.10M |
| 36 | XGN | Exagen Inc. | 110.41M | -2.14% | 154,941 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 92.39M | 1.98% | 14,125 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 40.05M | 1.54% | 12,736 | 25.83M |
| 39 | MDXH | MDxHealth SA | 28.57M | 1.45% | 482,730 | 110.97M |
| 40 | QUCY | Quantum Cyber N.V. | 26.53M | 22.54% | 11,401,431 | 537.08K |
| 41 | MBAI | Check-Cap Ltd. | 10.50M | 3.60% | 73,141 | - |
| 42 | XWEL | XWELL, Inc. | 10.30M | 0.83% | 45,836 | 28.83M |
| 43 | ADVB | Advanced Biomed Inc. | 7.27M | -2.22% | 114,415 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 6.21M | -7.43% | 229,434 | 5.66M |
| 45 | NDRA | ENDRA Life Sciences Inc. | 6.14M | 8.55% | 28,193 | - |
| 46 | ISPC | iSpecimen Inc. | 4.07M | 2.91% | 51,258 | 1.03M |